Walgreens is suspending its quarterly dividend payments after 92 consecutive years, the company said Thursday. The drugstore said the decision by its board of directors to pause the quarterly ...

To receive daily news and insights, subscribe to our free daily Retail Dive newsletter. Walgreens is suspending its quarterly dividend payments after 92 consecutive years, the company said Thursday.

Walgreens is suspending its quarterly dividend payments to stockholders as the company works to free up cash to reduce debt and fund its long-term turnaround.

Walgreens Boots Alliance shares sank Friday after the pharmacy chain suspended its quarterly dividend to shore up its finances while it works to turn around its business.

Walgreens' CEO talked about the flip side of investing in increased security on a recent earnings call. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of ...

Walgreens Boots Alliance (WBA) stock was one of the worst-performing S&P 500 stocks on Friday, January 31, after the drugstore chain announced it is suspending its quarterly dividend. Track all ...

Shares of Walgreens dove early Friday, a day after the drugstore chain said it was suspending its dividend, breaking a streak of quarterly shareholder payouts that stretches back more than 90 years.

The improving retail pharmacy business of Walgreens Boots Alliance and comments ... expectations and a combination of revenue growth and cost control,” Wentworth said on a call with analysts ...

Investors appear bullish on the company's progress in its $1 billion cost-cutting program. Shares of Walgreens Boots Alliance have risen 35% since the company reported its Q1 financials on Jan. 10.

A Walgreens store near the Centre of Tallahassee ... The move is part of a multi-year cost-cutting program under CEO Tim Wentworth, according to an October 2024 article in USA Today.

He said Walgreens is working with PBMs to balance brand-name drugs and generics, carve out new categories for high-cost drugs such as GLP-1s and implement alternative payment models. "Our goal is ...